unusual performance in Hong Kong stocks | Maiweishi Biology-B (02493.HK) rose more than 3%, its subsidiary Maiweishi Vision has reached a strategic cooperation with Vmo Bio, focusing on ophthalmic inflammation and eye immunity areas.
According to the iFast Financial APP, Meinian Health-B (02493.HK) rose more than 3%, as of the drafting of the article, it rose 2.72%, closing at 26.48 Hong Kong dollars, with a turnover of 6.4846 million Hong Kong dollars.
Latest
